However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What Alzheimer's disease is The difference between Alzheimer's and dementia The ...

Namenda (memantine) is a prescription drug that’s used to treat dementia related to Alzheimer’s disease. This drug can interact with other medications and some supplements. For example ...

Dr. Jeanne Wei, triple board-certified M.D. and Ph.D., Chair, Reynolds Department of Geriatrics & Executive Director of the Reynolds Institute on Aging (RIOA), gives Nichole an in-depth review of the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

The doctor said his pulse rate is low, and the medications have a tendency to lower the pulse even more, which can be dangerous. His Alzheimer's stage is 4-5, and his MMSE score was 5 out of 30. Is ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...

(“Alpha”) of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets ) (“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...